Study of GS-0272 in Participants With Rheumatoid Arthritis or Systemic Lupus Erythematosus

Conditions:   Rheumatoid Arthritis;   Systemic Lupus Erythematosus Interventions:   Drug: GS-0272;   Drug: Placebo Sponsor:   Gilead Sciences Not yet recruiting

Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials